continued

S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable

S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable

S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable

Karren Franco 12 May، 2025

Amman, Jordan S&P has announced on 8 May that it has raised its long-term issuer credit rating...

GCC visitor numbers to Germany continued to grow in 2024 استمرار نمو أعداد زوار دول مجلس التعاون الخليجي إلى ألمانيا في عام 2024

استمرار نمو أعداد زوار دول مجلس التعاون الخليجي إلى ألمانيا في عام 2024

GCC visitor numbers to Germany continued to grow in 2024

manager 29 April، 2025

Dubai, United Arab Emirates, 28 April 2025: The German National Tourist Office GCC (GNTO GCC) announced today...

Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated

Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated

Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated

Karren Franco 25 April، 2024

Amman, Jordan Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current...